
Big pharma urged to address vaccine inequity
In separate virtual addresses to the shareholders of Moderna, Pfizer, and Johnson & Johnson (JNJ), Oxfam called on the pharmaceutical corporations to improve COVID-19 vaccine

In separate virtual addresses to the shareholders of Moderna, Pfizer, and Johnson & Johnson (JNJ), Oxfam called on the pharmaceutical corporations to improve COVID-19 vaccine

An Oxfam resolution before Moderna shareholders received 24% of the nominal vote, or 29% of the independent vote factoring in the 17% of the vote

43 African governments are facing expenditure cuts totalling $183 billion (equivalent to 5.4 percent of GDP) over the next five years, reveals new analysis from
87 percent of the International Monetary Fund’s (IMF) COVID-19 loans are requiring developing countries that have been denied equal access to vaccines and are facing

Over a quarter of a billion more people could crash into extreme levels of poverty in 2022 because of Covid-19, rising global inequality and the

Ukraine conflict worsening food crisis and decimating families purchasing power Wheat flour reserves in the Occupied Palestinian Territory could be exhausted within three weeks and

Increased flooding in South Sudan threatens to deepen the dire hunger crisis, with an estimated 8.3 million people expected to experience severe food insecurity in

Responding to the publication today of the IPCC’s Working Group III report on climate change mitigation, Oxfam’s Climate Policy Lead Nafkote Dabi said: “This IPCC

Twenty-three NGOs are jointly urging the EU and European countries to work together to put into action their refugee response commitments in light of the

Today, we write to celebrate Jo, a compassionate and determined supporter of Oxfam Aotearoa. Jo and her partner are parents to two young children (and